Selected research
Market Analysis & Forecast
Global Hormones Test Service Market Analysis and Forecast 2026-2032
Market perspective
The global Hormones Test Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Hormones Test Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Hormones Test Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Hormones Test Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Hormones Test Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Hormones Test Service include MP Biomedicals, Randox, Forth, Quest, Thriva, Testing, LetsGet Checked, Medichecks and iMEDICAL, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Hormones Test Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Hormones Test Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Hormones Test Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hormones Test Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Hormones Test Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Hormones Test Service revenue, projected growth trends, production technology, application and end-user industry.
Hormones Test Service Segment by Company
MP Biomedicals
Randox
Forth
Quest
Thriva
Testing
LetsGet Checked
Medichecks
iMEDICAL
Lab Me
Veracity
Goodbody
Balance My Hormones
Genova
Hipro Biotechnology
Hormones Test Service Segment by Type
Blood Test
Saliva Test
Hormones Test Service Segment by Application
Female
Male
Hormones Test Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hormones Test Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hormones Test Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hormones Test Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Hormones Test Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Hormones Test Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hormones Test Service revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Blood Test
- Saliva Test
Applications
- Female
- Male
Companies covered
- MP Biomedicals
- Randox
- Forth
- Quest
- Thriva
- Testing
- LetsGet Checked
- Medichecks
- iMEDICAL
- Lab Me
- Veracity
- Goodbody
- Balance My Hormones
- Genova
- Hipro Biotechnology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Hormones Test Service Market by Type
- 1.2.1 Global Hormones Test Service Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Blood Test
- 1.2.3 Saliva Test
- 1.3 Hormones Test Service Market by Application
- 1.3.1 Global Hormones Test Service Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Female
- 1.3.3 Male
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Hormones Test Service Market Dynamics
- 2.1 Hormones Test Service Industry Trends
- 2.2 Hormones Test Service Industry Drivers
- 2.3 Hormones Test Service Industry Opportunities and Challenges
- 2.4 Hormones Test Service Industry Restraints
3 Global Growth Perspective
- 3.1 Global Hormones Test Service Market Perspective (2021-2032)
- 3.2 Global Hormones Test Service Growth Trends by Region
- 3.2.1 Global Hormones Test Service Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Hormones Test Service Market Size by Region (2021-2026)
- 3.2.3 Global Hormones Test Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Hormones Test Service Revenue by Players
- 4.1.1 Global Hormones Test Service Revenue by Players (2021-2026)
- 4.1.2 Global Hormones Test Service Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Hormones Test Service Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Hormones Test Service Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Hormones Test Service Key Players Headquarters & Area Served
- 4.4 Global Hormones Test Service Players, Product Type & Application
- 4.5 Global Hormones Test Service Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Hormones Test Service Market CR5 and HHI
- 4.6.3 2025 Hormones Test Service Tier 1, Tier 2, and Tier 3
5 Hormones Test Service Market Size by Type
- 5.1 Global Hormones Test Service Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Hormones Test Service Revenue by Type (2021-2032)
- 5.3 Global Hormones Test Service Revenue Market Share by Type (2021-2032)
6 Hormones Test Service Market Size by Application
- 6.1 Global Hormones Test Service Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Hormones Test Service Revenue by Application (2021-2032)
- 6.3 Global Hormones Test Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 MP Biomedicals
- 7.1.1 MP Biomedicals Company Information
- 7.1.2 MP Biomedicals Business Overview
- 7.1.3 MP Biomedicals Hormones Test Service Revenue and Gross Margin (2021-2026)
- 7.1.4 MP Biomedicals Hormones Test Service Product Portfolio
- 7.1.5 MP Biomedicals Recent Developments
- 7.2 Randox
- 7.2.1 Randox Company Information
- 7.2.2 Randox Business Overview
- 7.2.3 Randox Hormones Test Service Revenue and Gross Margin (2021-2026)
- 7.2.4 Randox Hormones Test Service Product Portfolio
- 7.2.5 Randox Recent Developments
- 7.3 Forth
- 7.3.1 Forth Company Information
- 7.3.2 Forth Business Overview
- 7.3.3 Forth Hormones Test Service Revenue and Gross Margin (2021-2026)
- 7.3.4 Forth Hormones Test Service Product Portfolio
- 7.3.5 Forth Recent Developments
- 7.4 Quest
- 7.4.1 Quest Company Information
- 7.4.2 Quest Business Overview
- 7.4.3 Quest Hormones Test Service Revenue and Gross Margin (2021-2026)
- 7.4.4 Quest Hormones Test Service Product Portfolio
- 7.4.5 Quest Recent Developments
- 7.5 Thriva
- 7.5.1 Thriva Company Information
- 7.5.2 Thriva Business Overview
- 7.5.3 Thriva Hormones Test Service Revenue and Gross Margin (2021-2026)
- 7.5.4 Thriva Hormones Test Service Product Portfolio
- 7.5.5 Thriva Recent Developments
- 7.6 Testing
- 7.6.1 Testing Company Information
- 7.6.2 Testing Business Overview
- 7.6.3 Testing Hormones Test Service Revenue and Gross Margin (2021-2026)
- 7.6.4 Testing Hormones Test Service Product Portfolio
- 7.6.5 Testing Recent Developments
- 7.7 LetsGet Checked
- 7.7.1 LetsGet Checked Company Information
- 7.7.2 LetsGet Checked Business Overview
- 7.7.3 LetsGet Checked Hormones Test Service Revenue and Gross Margin (2021-2026)
- 7.7.4 LetsGet Checked Hormones Test Service Product Portfolio
- 7.7.5 LetsGet Checked Recent Developments
- 7.8 Medichecks
- 7.8.1 Medichecks Company Information
- 7.8.2 Medichecks Business Overview
- 7.8.3 Medichecks Hormones Test Service Revenue and Gross Margin (2021-2026)
- 7.8.4 Medichecks Hormones Test Service Product Portfolio
- 7.8.5 Medichecks Recent Developments
- 7.9 iMEDICAL
- 7.9.1 iMEDICAL Company Information
- 7.9.2 iMEDICAL Business Overview
- 7.9.3 iMEDICAL Hormones Test Service Revenue and Gross Margin (2021-2026)
- 7.9.4 iMEDICAL Hormones Test Service Product Portfolio
- 7.9.5 iMEDICAL Recent Developments
- 7.10 Lab Me
- 7.10.1 Lab Me Company Information
- 7.10.2 Lab Me Business Overview
- 7.10.3 Lab Me Hormones Test Service Revenue and Gross Margin (2021-2026)
- 7.10.4 Lab Me Hormones Test Service Product Portfolio
- 7.10.5 Lab Me Recent Developments
- 7.11 Veracity
- 7.11.1 Veracity Company Information
- 7.11.2 Veracity Business Overview
- 7.11.3 Veracity Hormones Test Service Revenue and Gross Margin (2021-2026)
- 7.11.4 Veracity Hormones Test Service Product Portfolio
- 7.11.5 Veracity Recent Developments
- 7.12 Goodbody
- 7.12.1 Goodbody Company Information
- 7.12.2 Goodbody Business Overview
- 7.12.3 Goodbody Hormones Test Service Revenue and Gross Margin (2021-2026)
- 7.12.4 Goodbody Hormones Test Service Product Portfolio
- 7.12.5 Goodbody Recent Developments
- 7.13 Balance My Hormones
- 7.13.1 Balance My Hormones Company Information
- 7.13.2 Balance My Hormones Business Overview
- 7.13.3 Balance My Hormones Hormones Test Service Revenue and Gross Margin (2021-2026)
- 7.13.4 Balance My Hormones Hormones Test Service Product Portfolio
- 7.13.5 Balance My Hormones Recent Developments
- 7.14 Genova
- 7.14.1 Genova Company Information
- 7.14.2 Genova Business Overview
- 7.14.3 Genova Hormones Test Service Revenue and Gross Margin (2021-2026)
- 7.14.4 Genova Hormones Test Service Product Portfolio
- 7.14.5 Genova Recent Developments
- 7.15 Hipro Biotechnology
- 7.15.1 Hipro Biotechnology Company Information
- 7.15.2 Hipro Biotechnology Business Overview
- 7.15.3 Hipro Biotechnology Hormones Test Service Revenue and Gross Margin (2021-2026)
- 7.15.4 Hipro Biotechnology Hormones Test Service Product Portfolio
- 7.15.5 Hipro Biotechnology Recent Developments
8 North America
- 8.1 North America Hormones Test Service Revenue (2021-2032)
- 8.2 North America Hormones Test Service Revenue by Type (2021-2032)
- 8.2.1 North America Hormones Test Service Revenue by Type (2021-2026)
- 8.2.2 North America Hormones Test Service Revenue by Type (2027-2032)
- 8.3 North America Hormones Test Service Revenue Share by Type (2021-2032)
- 8.4 North America Hormones Test Service Revenue by Application (2021-2032)
- 8.4.1 North America Hormones Test Service Revenue by Application (2021-2026)
- 8.4.2 North America Hormones Test Service Revenue by Application (2027-2032)
- 8.5 North America Hormones Test Service Revenue Share by Application (2021-2032)
- 8.6 North America Hormones Test Service Revenue by Country
- 8.6.1 North America Hormones Test Service Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Hormones Test Service Revenue by Country (2021-2026)
- 8.6.3 North America Hormones Test Service Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Hormones Test Service Revenue (2021-2032)
- 9.2 Europe Hormones Test Service Revenue by Type (2021-2032)
- 9.2.1 Europe Hormones Test Service Revenue by Type (2021-2026)
- 9.2.2 Europe Hormones Test Service Revenue by Type (2027-2032)
- 9.3 Europe Hormones Test Service Revenue Share by Type (2021-2032)
- 9.4 Europe Hormones Test Service Revenue by Application (2021-2032)
- 9.4.1 Europe Hormones Test Service Revenue by Application (2021-2026)
- 9.4.2 Europe Hormones Test Service Revenue by Application (2027-2032)
- 9.5 Europe Hormones Test Service Revenue Share by Application (2021-2032)
- 9.6 Europe Hormones Test Service Revenue by Country
- 9.6.1 Europe Hormones Test Service Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Hormones Test Service Revenue by Country (2021-2026)
- 9.6.3 Europe Hormones Test Service Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Hormones Test Service Revenue (2021-2032)
- 10.2 China Hormones Test Service Revenue by Type (2021-2032)
- 10.2.1 China Hormones Test Service Revenue by Type (2021-2026)
- 10.2.2 China Hormones Test Service Revenue by Type (2027-2032)
- 10.3 China Hormones Test Service Revenue Share by Type (2021-2032)
- 10.4 China Hormones Test Service Revenue by Application (2021-2032)
- 10.4.1 China Hormones Test Service Revenue by Application (2021-2026)
- 10.4.2 China Hormones Test Service Revenue by Application (2027-2032)
- 10.5 China Hormones Test Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Hormones Test Service Revenue (2021-2032)
- 11.2 Asia Hormones Test Service Revenue by Type (2021-2032)
- 11.2.1 Asia Hormones Test Service Revenue by Type (2021-2026)
- 11.2.2 Asia Hormones Test Service Revenue by Type (2027-2032)
- 11.3 Asia Hormones Test Service Revenue Share by Type (2021-2032)
- 11.4 Asia Hormones Test Service Revenue by Application (2021-2032)
- 11.4.1 Asia Hormones Test Service Revenue by Application (2021-2026)
- 11.4.2 Asia Hormones Test Service Revenue by Application (2027-2032)
- 11.5 Asia Hormones Test Service Revenue Share by Application (2021-2032)
- 11.6 Asia Hormones Test Service Revenue by Country
- 11.6.1 Asia Hormones Test Service Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Hormones Test Service Revenue by Country (2021-2026)
- 11.6.3 Asia Hormones Test Service Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Hormones Test Service Revenue (2021-2032)
- 12.2 SAMEA Hormones Test Service Revenue by Type (2021-2032)
- 12.2.1 SAMEA Hormones Test Service Revenue by Type (2021-2026)
- 12.2.2 SAMEA Hormones Test Service Revenue by Type (2027-2032)
- 12.3 SAMEA Hormones Test Service Revenue Share by Type (2021-2032)
- 12.4 SAMEA Hormones Test Service Revenue by Application (2021-2032)
- 12.4.1 SAMEA Hormones Test Service Revenue by Application (2021-2026)
- 12.4.2 SAMEA Hormones Test Service Revenue by Application (2027-2032)
- 12.5 SAMEA Hormones Test Service Revenue Share by Application (2021-2032)
- 12.6 SAMEA Hormones Test Service Revenue by Country
- 12.6.1 SAMEA Hormones Test Service Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Hormones Test Service Revenue by Country (2021-2026)
- 12.6.3 SAMEA Hormones Test Service Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst